Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

41.49
Delayed Data
As of Jul 27
 -0.50 / -1.19%
Today’s Change
30.89
Today|||52-Week Range
57.41
+15.70%
Year-to-Date

Today’s Trading

Previous close41.99
Today’s open41.48
Day’s range41.03 - 41.64
Volume2,984,455
Average volume (3 months)2,095,205
Market cap$80.5B
Dividend yield3.23%
Data as of 4:02pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.75%
Revenue growth (last year)+3.81%
P/E ratio2.7
Price/Sales5.48
Price/Book16.38

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-5.06-14.91%
AGNAllergan-1.99-0.78%
ABTAbbott Laboratories-0.29-0.58%
LLYEli Lilly and Co+1.18+1.44%
Data as of 4:02pm ET, 07/27/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts